Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Digestive Diseases and Sciences|December 5, 2019
Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort StudyPatrick S Cernoch, Nicolas Fournier, Jonas Zeitz, et al.
United European Gastroenterology Journal|September 9, 2024
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency surveyNadia Wespi, Stephan Vavricka, Stephan Brand, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2021
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel diseaseSebastian Bruno Ulrich Jordi, Federica Botte, Brian Matthew Lang, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activitiesPhilipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Digestive Diseases (Basel, Switzerland)|June 9, 2017
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III SurveyStephan R Vavricka, Milos Spasojevic, Gerhard Rogler, et al.
Plos One|September 15, 2016
A Genome-Wide siRNA Screen Implicates Spire1/2 in SipA-Driven Salmonella Typhimurium Host Cell InvasionDaniel Andritschke, Sabrina Dilling, Mario Emmenlauer, et al.
Plos Pathogens|August 23, 2012
Near surface swimming of Salmonella Typhimurium explains target-site selection and cooperative invasionBenjamin Misselwitz, Naomi Barrett, Saskia Kreibich, et al.
Therapeutic Advances in Gastroenterology|August 11, 2023
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort studyBrian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, et al.
Pageof 15